Literature DB >> 2429839

Infantile Refsum disease: deficiency of catalase-containing particles (peroxisomes), alkyldihydroxyacetone phosphate synthase and peroxisomal beta-oxidation enzyme proteins.

R J Wanders, R B Schutgens, G Schrakamp, H van den Bosch, J M Tager, A W Schram, T Hashimoto, B T Poll-Thé, J M Saudubrau.   

Abstract

In recent years a number of biochemical abnormalities have been described in patients with the infantile form of Refsum disease, including the accumulation of very long chain fatty acids, trihydroxycoprostanoic acid and pipecolic acid. In this paper we show that catalase-containing particles (peroxisomes), alkyl dihydroxyacetone phosphate synthase and acyl-CoA oxidase protein are deficient in patients with infantile Refsum disease. These findings suggest that in the infantile form of Refsum disease, as in the cerebro-hepato-renal (Zellweger) syndrome the multiplicity of biochemical abnormalities is due to a deficiency of peroxisomes and hence to a generalized loss of peroxisomal functions. As a consequence the infantile form of Refsum disease can be diagnosed biochemically by methods already available for the prenatal and postnatal diagnosis of the cerebro-hepato-renal (Zellweger) syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429839     DOI: 10.1007/bf00446057

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  20 in total

1.  Refsum's disease, adrenoleucodystrophy, and the Zellweger syndrome.

Authors:  O Stokke; S Skrede; J Ek; I Björkhem
Journal:  Scand J Clin Lab Invest       Date:  1984-09       Impact factor: 1.713

2.  Properties of guinea pig liver peroxisomal dihydroxyacetone phosphate acyltransferase.

Authors:  C L Jones; A K Hajra
Journal:  J Biol Chem       Date:  1980-09-10       Impact factor: 5.157

3.  Identification of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestan-26-oic acid, an intermediate in cholic acid synthesis, in the plasma of patients with infantile Refsum's disease.

Authors:  A Poulos; M J Whiting
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

4.  Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome.

Authors:  R B Schutgens; G J Romeyn; R J Wanders; H van den Bosch; G Schrakamp; H S Heymans
Journal:  Biochem Biophys Res Commun       Date:  1984-04-16       Impact factor: 3.575

5.  Cyanide-insensitive and clofibrate enhanced beta-oxidation of dodecanedioic acid in rat liver. An indication of peroxisomal beta-oxidation of N-dicarboxylic acids.

Authors:  P B Mortensen; S Kølvraa; N Gregersen; K Rasmussen
Journal:  Biochim Biophys Acta       Date:  1982-11-12

6.  Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.

Authors:  I Singh; A E Moser; S Goldfischer; H W Moser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

7.  Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes.

Authors:  N S Datta; G N Wilson; A K Hajra
Journal:  N Engl J Med       Date:  1984-10-25       Impact factor: 91.245

8.  Alkyl dihydroxyacetone phosphate synthase in human fibroblasts and its deficiency in Zellweger syndrome.

Authors:  G Schrakamp; C F Roosenboom; R B Schutgens; R J Wanders; H S Heymans; J M Tager; H van den Bosch
Journal:  J Lipid Res       Date:  1985-07       Impact factor: 5.922

9.  Subcellular localization of acyl coenzyme A: dihydroxyacetone phosphate acyltransferase in rat liver peroxisomes (microbodies).

Authors:  A K Hajra; C L Burke; C L Jones
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

10.  Patterns of Refsum's disease. Phytanic acid oxidase deficiency.

Authors:  A Poulos; A C Pollard; J D Mitchell; G Wise; G Mortimer
Journal:  Arch Dis Child       Date:  1984-03       Impact factor: 3.791

View more
  11 in total

1.  Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells.

Authors:  S Yajima; Y Suzuki; N Shimozawa; S Yamaguchi; T Orii; Y Fujiki; T Osumi; T Hashimoto; H W Moser
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

Review 2.  The inborn errors of peroxisomal beta-oxidation: a review.

Authors:  R J Wanders; C W van Roermund; R B Schutgens; P G Barth; H S Heymans; H van den Bosch; J M Tager
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Infantile Refsum disease: an inherited peroxisomal disorder. Comparison with Zellweger syndrome and neonatal adrenoleukodystrophy.

Authors:  B T Poll-The; J M Saudubray; H A Ogier; M Odièvre; J M Scotto; L Monnens; L C Govaerts; F Roels; A Cornelis; R B Schutgens
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

4.  Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.

Authors:  B T Poll-The; O H Skjeldal; O Stokke; A Poulos; F Demaugre; J M Saudubray
Journal:  Hum Genet       Date:  1989-01       Impact factor: 4.132

5.  Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.

Authors:  R J Wanders; C W van Roermund; M J van Wijland; R B Schutgens; J Heikoop; H van den Bosch; A W Schram; J M Tager
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

6.  Autopsy findings in two siblings with infantile Refsum disease.

Authors:  C W Chow; A Poulos; A J Fellenberg; J Christodoulou; D M Danks
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis.

Authors:  S Brul; A Westerveld; A Strijland; R J Wanders; A W Schram; H S Heymans; R B Schutgens; H van den Bosch; J M Tager
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

8.  Treatment of infantile phytanic acid storage disease: clinical, biochemical and ultrastructural findings in two children treated for 2 years.

Authors:  E F Robertson; A Poulos; P Sharp; J Manson; G Wise; A Jaunzems; R Carter
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

9.  Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.

Authors:  A Poulos; P Sharp; A J Fellenberg; D W Johnson
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

10.  A sibship with a mild variant of Zellweger syndrome.

Authors:  P G Barth; R B Schutgens; R J Wanders; H S Heymans; A E Moser; H W Moser; E M Bleeker-Wagemakers; K Jansonius-Schultheiss; M Derix; G F Nelck
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.